Today: 17 May 2026
Microsoft stock (MSFT) ends Friday lower; Xbox shake-up and AI spending cues in focus for Monday
21 February 2026
2 mins read

Microsoft stock (MSFT) ends Friday lower; Xbox shake-up and AI spending cues in focus for Monday

New York, February 21, 2026, 10:57 EST — Market closed.

  • Microsoft ended off 0.3% at $397.23, trailing a wider advance in tech stocks.
  • Microsoft tapped Asha Sharma to head up gaming, stepping in as Phil Spencer, who led Xbox for years, retires. Sarah Bond, Xbox’s chief operating officer, is also on her way out.
  • Nvidia’s earnings are on deck this week, with traders also keyed in on inflation-driven rate wagers—either of which could jolt big tech.

Microsoft dipped 0.3% Friday, closing at $397.23 — lagging behind the broader market as the session ended. Shares moved in a range from $396.47 up to $402.31, staying well under the 52-week peak of $468.25.

Microsoft’s outsized role in both the Nasdaq and S&P 500 means even minor changes can sway the indexes. Investors, facing a gaming unit leadership shake-up and digesting new moves in policy and inflation, head into Monday with plenty to chew on.

The timing coincides with Wall Street’s ongoing debate over the value of “AI spending” and its speed in generating revenue. For Microsoft, the focus falls on Azure, Copilot, and, more and more, AI integration in areas like gaming.

U.S. equities finished the week on a positive note Friday, with the Supreme Court’s decision to overturn President Donald Trump’s broad tariffs sending stocks higher. Investors faced a weak GDP reading and signs of hotter inflation, but shrugged them off. The Dow climbed 0.47%, the S&P 500 advanced 0.69%, and the Nasdaq rallied 0.90%, Reuters reported. Tim Ghriskey, senior portfolio strategist at Ingalls & Snyder, pointed out that markets viewed tariffs as a drag on both the economy and company profits, though he warned about potential fallout from whatever comes next.

Inflation remains a hurdle. The “core” personal consumption expenditures price index—closely watched by the Federal Reserve and excluding food and energy—climbed 0.4% in December, coming in hotter than economists anticipated, according to Reuters. That print has fueled bets the Fed could hold off on rate cuts until at least June, a scenario that keeps the squeeze on tech names banking on distant earnings growth. Reuters

Microsoft’s gaming division took the spotlight late Friday with news that Phil Spencer is stepping down after 38 years at the company. Asha Sharma has been tapped to take over as executive vice president and CEO of gaming, with Spencer set to remain as an advisor into the summer. Sarah Bond, currently president and chief operating officer at Xbox, is also departing. Matt Booty takes on the role of chief content officer. “We will recommit to our core Xbox fans and players,” Sharma said. Satya Nadella, Microsoft’s CEO, noted that the leadership transition has been in the works since last year. Analyst Gil Luria at D.A. Davidson pointed out the move comes as AI increasingly shapes gaming tech. Reuters

After Microsoft’s gaming division took in Activision Blizzard and raised Xbox hardware prices amid cost pressures, changes followed. While moves like these don’t typically reshape Microsoft’s earnings model, they do have the power to shift sentiment around a business segment investors track closely for consumer appetite and margin volatility.

Microsoft kicked off the week by rolling out its new dividend schedule. The tech giant set a quarterly payout at $0.91 a share, according to an announcement. That dividend lands on March 12. Shares go ex-dividend Feb. 19.

Even so, near-term price action probably hinges more on the market’s next signals around AI demand and funding costs than anything tied to Xbox. Tariff policy isn’t out of the picture despite the court decision, while inflation shocks have a way of slamming the priciest stocks if rates start to adjust.

Here’s the risk: if the macro environment stays rough, investors stick to defensive bets, and even a whiff of weaker AI returns could yank expectations lower for the big names that drove the rally. Gaming? Still a weak point if consumers start tightening up on extras and console competition keeps running hot.

Midweek brings the event traders have circled: Nvidia reports results Wednesday, Feb. 25. Eyes are on whether the chipmaker delivers signs of profit from the worldwide AI push, and if the “Magnificent Seven” trade gets its spark back, according to Reuters. Reuters

Stock Market Today

  • Monster Beverage (MNST) Stock Near Fair Value After Multi-Year Gains
    May 16, 2026, 9:18 PM EDT. Monster Beverage (MNST) has delivered strong returns, rising nearly 89% over five years. The stock recently traded at around $87, modestly above its estimated intrinsic value of $80.02 based on a Discounted Cash Flow (DCF) model. This valuation approach projects Monster's free cash flow growing from $1.94 billion to over $3 billion by 2030. Despite impressive share price gains, the DCF suggests Monster is roughly 8.8% overvalued, indicating current prices are close to fair value rather than significantly overpriced. While the company's position in the US energy drink market supports growth prospects, its valuation score was 0 out of 6 on standard metrics, urging caution for new investors. Traders should monitor valuation shifts and market developments to time entries appropriately.

Latest articles

Joby Aviation Slides Monday With Air-Taxi in Focus

Joby Aviation Slides Monday With Air-Taxi in Focus

17 May 2026
Joby Aviation shares closed Friday at $10.36, down 2.6% for the day and 4.7% for the week. CEO JoeBen Bevirt-linked trusts sold over 421,000 shares under a preset 10b5-1 plan, filings showed. The stock traded between $10.04 and $10.58 during a volatile week. Broader markets and eVTOL sector peers also declined.
ImmunityBio’s BCG Agreement Puts Monday’s Trading in Focus

ImmunityBio’s BCG Agreement Puts Monday’s Trading in Focus

17 May 2026
ImmunityBio closed at $7.97 Friday, down 2.2% after announcing exclusive U.S. rights to Japan BCG Laboratory’s Tokyo-172 strain for bladder cancer therapy. The Tokyo strain remains investigational in the U.S. and is not FDA-approved. Nasdaq was closed for the weekend; the next trading session is Monday. ImmunityBio’s Q1 product revenue rose to $44.2 million with $380.9 million in cash and securities.
Infleqtion Stock Just Took a Hit After Record Revenue — What Could Move INFQ Next

Infleqtion Stock Just Took a Hit After Record Revenue — What Could Move INFQ Next

17 May 2026
Infleqtion Inc. shares fell 10.95% to $12.44 Friday, capping a rough week for quantum tech stocks. The company reported a first-quarter net loss of $30.3 million on $9.5 million in revenue, with 85% from government contracts. Infleqtion launched a new RF sensing platform and raised its 2026 revenue outlook, but warned of continued operating losses.
Synopsys Shares Dropped for the Week, Looking to May 27 for Direction

Synopsys Shares Dropped for the Week, Looking to May 27 for Direction

17 May 2026
Synopsys shares fell 1.49% Friday to $502.42, ending the week down 2.72% amid a broad tech selloff and news that Coatue Management cut its stake by 54%. The Nasdaq Composite dropped 1.54% Friday, while the Philadelphia semiconductor index slid 4%. Synopsys will report fiscal Q2 results after the market closes on May 27. Wells Fargo and Citigroup raised their price targets for the stock earlier in the week.
Anglo American JSE share price: De Beers writedown puts Teck deal and dividend dates in the spotlight
Previous Story

Anglo American JSE share price: De Beers writedown puts Teck deal and dividend dates in the spotlight

Alphabet GOOG stock jumps 3.7% — what to watch next week for Google shares
Next Story

Alphabet GOOG stock jumps 3.7% — what to watch next week for Google shares

Go toTop